Loading...
NPI 1356325195 · Federal Way, WA · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Brenda Myers Powell is a retina specialist (ophthalmology) physician provider located in Federal Way, Washington. This profile covers 18 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Brenda Myers Powell |
| Address | 33915 1st Way S |
| City | Federal Way |
| State | WA |
| ZIP | 98003 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | December 5, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.2M |
| Medicaid | $0 |
This provider is effectively Medicare-only: Total Medicare revenue is $2.2M while Total Medicaid revenue is $0, indicating no Medicaid billing on file. The NPI was enumerated on 2005-12-05 (~21 years ago), showing long tenure in the Medicare program and an established practice presence in Federal Way, WA.
Revenue is highly concentrated in anti-VEGF and intravitreal procedures: the precomputed top three Medicare codes (J0178, J2777, and 67028) account for 91.2% of this provider's Medicare revenue, with J0178 at 43.8%, J2777 at 41.8%, and 67028 at 5.6%. This concentration implies that a small set of drug and procedure codes drives the vast majority of reimbursement for this clinician.
Clinical/service-line profile is injection- and imaging-centered: the top revenue codes J0178 (aflibercept) and J2777 (faricimab) plus procedure 67028 indicate a retina practice model focused on recurring intravitreal biologic injections for retinal disease management. Complementary imaging codes such as 92134 (OCT) and 92242 (angiography) appear in the top codes list, consistent with in-office diagnostic workflows that support frequent injection visits.
Competitive standing by code shows mixed but generally solid participation: J2777 ranks #262 of 2039 nationally (87th percentile; typical, unremarkable volume for this code), indicating above-median national activity for faricimab injections, while J0178 ranks #883 of 3204 (72th percentile; typical, unremarkable volume for this code) and 67028 ranks #1186 of 4255 (72th percentile; typical, unremarkable volume for this code), which place the provider as a typical-to-strong regional participant for these high-revenue services.
Ancillary diagnostic volumes reinforce a procedure-focused practice: 92134 ranks #2218 of 26868 (92th percentile; typical, unremarkable volume for this code) and 92250 ranks #1098 of 25087 (96th percentile; notably above typical national volume for this code), suggesting above-typical fundus photography and strong OCT utilization to support diagnosis and treatment monitoring in-office.
Evaluation-and-management activity is present but not the primary revenue driver: 99213 and 99214 together account for modest Medicare revenue ($23.7K and $23.1K respectively) and rank at relatively high national percentiles (99213 at #50390 of 457151, 89th percentile; 99214 at #133716 of 479517, 72th percentile; both labeled typical, unremarkable volume), consistent with routine follow-up visits that accompany a high-volume injection practice.
There are a few billing items that merit operational attention: J3490 (unclassified drugs) generated $30.1K on 26 claims with a $1156 avg paid/claim but ranks #2400 of 2838 (14th percentile; typical, unremarkable volume for this code), and J7999 (compounded drug) appears with $15.3K and ranks #450 of 1333 (66th percentile). Given the overall revenue concentration (top three codes = 91.2%), the practice’s financial performance is highly sensitive to changes in utilization or reimbursement for its primary biologic drug codes and intravitreal injection procedures.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
18 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,420 | $690 | $974.2K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 32,040 | $30 | $929.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,150 | $110 | $125.5K |
| 92242 | The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He… | 180 | $240 | $42.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 970 | $30 | $31.1K |
| J3490 | Unclassified drugs | 30 | $1,160 | $30.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 340 | $70 | $23.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 230 | $100 | $23.1K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 530 | $30 | $15.9K |
| J7999 | Compounded drug, not otherwise classified | 220 | $70 | $15.3K |
Showing 1–10 of 18
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
18 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J2777 | 14 | 50 | 12,780 | $30 | $599.7K |
| J0178 | 27 | 90 | 470 | $680 | $597.2K |
| 67028 | 34 | 110 | 550 | $90 | $72.9K |
| J3490 | 54 | 70 | 70 | $50 | $51.2K |
| 92242 | 4 | 20 | 50 | $210 | $19.7K |
| 92014 | 753 | 790 | 110 | $80 | $16.8K |
| J7999 | 22 | 70 | 150 | $70 | $15.9K |
| 99214 | 2,386 | 10,860 | 100 | $80 | $13.6K |
| 99215 | 3,189 | 4,320 | 40 | $120 | $8.4K |
| 92235 | 40 | 50 | 50 | $110 | $8.3K |
Showing 1–10 of 18
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 30 | $0 | $0 |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 40 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Washington providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Washington median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 50 | 60 | 710 | $40 | $81.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 74 | 100 | 240 | $10 | $22.2K |
Other providers in the same ZIP code as Brenda Myers Powell, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.